Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 2047-2053

  Foster, Brenda J ^a   Wiegand, Richard A ^a   Pugh, Susan ^a   LoRusso, Patricia M ^a   Rake, James ^b   Corbett, Thomas H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sanofi Winthrop Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

183577; 232759; ANTINEOPLASTIC AGENT; THIOXANTHENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA L 1210; LEUKOPENIA; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; COLONIC NEOPLASMS; FEMALE; HALF-LIFE; KIDNEY; LEUKEMIA L1210; LIVER; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED STRAINS; SULFONAMIDES; THIOXANTHENES; TISSUE DISTRIBUTION;

EID: 0030697057     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Corbett, T. H. A selective two-tumor soft assay for drug discovery. Proc. Am. Assoc. Cancer Res., 25: 325, 1986.
2. Corbett, T. H., Valeriote, F. A., Polin, L., Panchapor, C., Pugh, S., White, K., Lowichik, N., Knight, J., Bissery, M. D., Wozniak, A., LoRusso, P., Biernat, L., Polin, P., Knight, L., Piggar, S., Looney, D., Demchik, L., Jones, J., Blair, S., Palmer, K., Essenmacher, S., Lisow, L., Mattes, K. C., Cavanaugh, P. F., Rake, J. B., and Baker, L. Discovery of solid tumor active agents using a soft-agar-colony formation-disk-diffusion-assay. In: F. A. Valeriote, T. H. Corbett, and L. H. Baker (eds.). Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development, pp. 50-58. Boston: Kluwer Academic Publishers, 1990.
3. Corbett, T. H. A selective two-tumor soft assay for drug discovery. Proc. Am. Assoc. Cancer Res., 26: 332, 1985.
4. Legha, S. S., Grose, W. E., and Bodey, G. P. Phase I study of hycanthone. Cancer Treat. Rep., 62: 1173-1176, 1978.
5. Kovach, J. S., Moertel, C. G., Schutt, A. J., and Eagan, R. T. Phase I study of hycanthone. Cancer Treat. Rep., 63: 11-12, 1979.
6. Haq, M. M., Legha, S. S., Wiseman, C. W., and Bodey, G. P. Hepatotoxicity of hycanthone in patients with metastatic breast cancer. Cancer Treat. Rep., 64: 929-932, 1980.
7. Schutt, A. J., Dalton, R. J., Kovach, J. S., Moertel, C. G., and O'Connel, M. J. Phase II study of hycanthone in patients with advanced colorectal carcinoma. Cancer Treat. Rep., 67: 593-594, 1983.
8. Corbett, T., Lowichik, N., Pugh, S., Polin, L., Panchapor, C., White, K., Knight, J., Demchik, L., Jones, J., Jones, L., Biernat, L., LoRusso, P., Foster, B., Heilbrun, L., Rake, J., Mattes, K. C., Perni, R., Powles, R. G., Hlavac, A. G., Wentland, M. P., Coughlin, S. A., Baker, L., and Valeriote, F. Antitumor activity of N-[[1-[[2-(diethylamino)-ethyl]amino]-9-oxo-9H-thioxanthen-4-yl]methyl] methanesulfonamide (WIN33377) and analogs. Exp. Opin. Invest. Drugs. 3: 1281-1292, 1994.
9. Biernat, L., LoRusso, P., Lowichik, N., Panchapor, C., Pugh, S., Polin, L., Rake, J., Wentland, M., Valeriote, F., Baker, L., and Corbett, T. Preliminary evaluation of murine toxicities of thioxanthen-9-one antitumor agents. Proc. Am. Assoc. Cancer Res., 34: 434, 1993.
10. Polin, L., Lowichik, N., Panchapor, C., Pugh, S., Knight, J., White, K., Demchik, L., Jones, J., Jones, L., Cavanaugh, P., Mattes, K., Rake, J., Perni, R., Wentland, M., and Corbett, T. In-vivo evaluation of thioxanthen-9-ones anti-solid tumor activity. Proc. Am. Assoc. Cancer Res., 34: 435, 1993.
11. Coughlin, S. A., Danz, D. W., Klingbeil, K. M., Robinson, R. G., Perni, R. B., Wentland, M. P., and Rake, J. B. Mechanisms of action of 4-aminomethyl-thioxanthen-9-one anti-solid tumor agents. Proc. Am. Assoc. Cancer Res., 34: 381, 1993.
12. Wentland, M. P., Perni, R. B., Powles, R. G., Klingbeil, K.M., Robinson, R. G., and Rake, J. B. Thioxanthane antitumor agents: the effects of 7-methoxy and 7-hydroxy substitutions. Proc. Am. Assoc. Cancer Res., 35: 397, 1994.
13. LoRusso, P., Wozniak, A. J., Polin, L., Capps, D., Leopold, W. R., Werbel, L. M., Biernat, L., Dan, M. E., and Corbett, T. H. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. Cancer Res., 50: 4900-4905, 1990.
14. Jennrich, R. I., and Sampson, P. F. Application of stepwise regression to non-linear least squares estimation. Techometrics, 10: 63-72, 1968.
15. Ottaway, J. H. Normalization in the fitting of data by iterative methods. Biochem. J., 134: 729-736, 1973.
16. Wagner, J. G. Fundamentals of Clinical Pharmacokinetics, pp. 38-58. Chicago: Drug Intelligence Publications, 1975.